<SEC-DOCUMENT>0001558370-23-001226-index.html : 20230214 <SEC-HEADER>0001558370-23-001226.hdr.sgml : 20230214 <ACCEPTANCE-DATETIME>20230214074613 ACCESSION NUMBER: 0001558370-23-001226 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20230214 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230214 DATE AS OF CHANGE: 20230214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 23622555 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>tmb-20230214x8k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: tmb-20230214x8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>tmb-20230214xex99d1.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: tmb-20230214xex99d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>tmb-20230214xex99d1001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: tmb-20230214xex99d1001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>tmb-20230214xex99d1002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: tmb-20230214xex99d1002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>5 <FILENAME>tmb-20230214.xsd <DESCRIPTION>EX-101.SCH <TEXT> Document 5 - file: tmb-20230214.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.DEF <SEQUENCE>6 <FILENAME>tmb-20230214_def.xml <DESCRIPTION>EX-101.DEF <TEXT> Document 6 - file: tmb-20230214_def.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>7 <FILENAME>tmb-20230214_lab.xml <DESCRIPTION>EX-101.LAB <TEXT> Document 7 - file: tmb-20230214_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>8 <FILENAME>tmb-20230214_pre.xml <DESCRIPTION>EX-101.PRE <TEXT> Document 8 - file: tmb-20230214_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>9 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 9 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>10 <FILENAME>R2.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: R2.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>11 <FILENAME>tmb-20230214x8k_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: tmb-20230214x8k_htm.html
Document 11 - RAW XML: tmb-20230214x8k_htm.xml
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>12 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 12 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>13 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 13 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>15 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 15 - file: FilingSummary.html
Document 15 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>18 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 18 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>19 <FILENAME>0001558370-23-001226-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 19 - file: 0001558370-23-001226-xbrl.zip
</DOCUMENT> </SEC-DOCUMENT>